Lowe Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Lowe Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$395	Hold	3	–	–	﹤0.01%	378
2025 Q2	$318	Hold	3	–	–	﹤0.01%	352
2025 Q1	$372	Hold	3	–	–	﹤0.01%	356
2024 Q4	$369	Hold	3	–	–	﹤0.01%	347
2024 Q3	$334	Hold	3	–	–	﹤0.01%	305
2024 Q2	$320	Hold	3	–	–	﹤0.01%	303
2024 Q1	$361	Hold	3	–	–	﹤0.01%	294
2023 Q4	$369	Hold	3	–	–	﹤0.01%	300
2023 Q3	$388	Hold	3	–	–	﹤0.01%	291
2023 Q2	$372	Hold	3	–	–	﹤0.01%	339
2023 Q1	$439	Hold	3	–	–	﹤0.01%	332
2022 Q4	$478	Hold	3	–	–	﹤0.01%	334
2022 Q3	$0	Hold	3	–	–	﹤0.01%	344
2022 Q2	$0	Hold	3	–	–	﹤0.01%	322
2022 Q1	$0	Hold	3	–	–	﹤0.01%	325
2021 Q4	$0	Hold	3	–	–	﹤0.01%	301
2021 Q3	$0	Hold	3	–	–	﹤0.01%	288
2021 Q2	$1K	Buy	+3	New	+$520	﹤0.01%	262

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Lowe Wealth Advisors's JAZZ Position: Q3 2025 in Review

Lowe Wealth Advisors held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2025 at 3 shares worth $395. The position accounts for ﹤0.01% of the portfolio, ranked #378.

Lowe Wealth Advisors first reported a position in JAZZ in Q2 2021 and has held it in 18 quarters since. The position peaked at $1K in Q2 2021. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

Lowe Wealth Advisors held 3 shares of Jazz Pharmaceuticals worth $395 as of Q3 2025.
Lowe Wealth Advisors left its Jazz Pharmaceuticals share count unchanged in Q3 2025.
Jazz Pharmaceuticals made up ﹤0.01% of Lowe Wealth Advisors's portfolio in Q3 2025, its #378 holding.
Lowe Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 18 quarters since.
Lowe Wealth Advisors's Jazz Pharmaceuticals position peaked at $1K in Q2 2021.
503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Lowe Wealth Advisors's 13F filing for Q3 2025, filed 16 Oct 2025.